Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Colleen Sakon

6PUBLICATIONS
2CO-AUTHORS
Social epidemiologyPacific Peoples theory of change models for healthPharmacogenomicsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

Sort by Publication Date:
|Dec 28, 2022
Enoxaparin adherence for venous thromboembolism prophylaxis in hospitalized patients with sickle cell disease.

Colleen Sakon, Miley Nikirk, Andrew Ross Wickman O'Brien

|Dec 09, 2022
A survey assessing the impact of COVID-19 and elexacaftor/tezacaftor/ifavacaftor on both physical and mental health in adults with cystic fibrosis.

Colleen Sakon, Hilary Vogt, Cynthia D Brown

|Nov 02, 2022
Opportunity for pharmacogenetics testing in patients with sickle cell anemia.

Katherine A Gallaway, Colleen Sakon, Jefney Ongeri

|Jun 07, 2022
Pharmacogenomics: a tool to improve medication safety and efficacy in patients with cystic fibrosis.

Colleen M Sakon, Emma M Tillman

|Dec 30, 2021
Opportunity for pharmacogenomic testing in patients with cystic fibrosis.

Colleen Sakon, Leah A Alicea, Heather Patacca

|Mar 14, 2020
Neurotoxicity in adult patients with cystic fibrosis using polymyxin B for acute pulmonary exacerbations.

Nick Rekis, Madelaine Ambrose, Colleen Sakon

Pageof 1

Frequent Collaborators

4 joint publications

Emma M Tillman

1 joint publications

Katherine A Gallaway

Frequent Collaborators

4 joint publications

Emma M Tillman

1 joint publications

Katherine A Gallaway

Top Related Videos

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
11:17

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood

Published on : Oct 12, 2012

13.8K
Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients
06:14

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Published on : Oct 15, 2017

8.4K
A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

1.8K
See more related videos

Top Related Videos

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
11:17

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood

Published on : Oct 12, 2012

13.8K
Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients
06:14

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Published on : Oct 15, 2017

8.4K
A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

1.8K
See more related videos